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Mutations in ClC-5 cause Dent’s disease, a disorder associated
with low molecular weight proteinuria, hyperphosphaturia,
and kidney stones. ClC-5 is a Cl/Hþ -exchanger
predominantly expressed in the kidney, where it facilitates
the acidification of proximal tubular endosomes. The
reduction in proximal tubular endocytosis resulting from a
lack of ClC-5 raises the luminal concentration of filtered
proteins and peptides like parathyroid hormone (PTH). The
increase in PTH may explain the hyperphosphaturia observed
in Dent’s disease. Expression profiling, quantitative reverse
transcriptase-polymerase chain reaction (qRT-PCR), and
hormone measurements were used to investigate whether
the disruption of ClC-5 affects other signalling pathways.
Although the upregulation of 25(OH)2-vitamin D3
1a-hydroxylase and downregulation of vitamin D3
24-hydroxylase suggested an increased formation of
1,25(OH)2-vitamin D3, the concentration of this active
metabolite was reduced in the serum of ClC-5 knockout
(KO) mice. However, target genes of 1,25(OH)2-vitamin
D3 were upregulated in KO kidneys. Expression analysis
of intestine and bone revealed that the upregulation of
1,25(OH)2-vitamin D3 target genes was kidney intrinsic
and not systemic. In spite of reduced serum levels of
1,25(OH)2-vitamin D3 in ClC-5 KO mice, 1,25(OH)2-vitamin D3
is increased in later nephron segments as a consequence
of impaired proximal tubular endocytosis. This leads to a
kidney-specific stimulation of 1,25(OH)2-vitamin D3 target
genes that may contribute to the pathogenesis of Dent’s
disease. The activation of genes in distal nephron segments
by hormones that are normally endocytosed in the proximal
tubule may extend to other pathways like those activated by
retinoic acid.
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ClC-5 belongs to the intracellular branch of the CLC gene
family of chloride channels and transporters. It is most
prominently expressed in the kidney, where it is present in
vesicles of proximal tubules (PTs) and of intercalated cells of
the collecting duct.1 Like other intracellular CLC proteins,
ClC-5 resides predominantly in the endocytic pathway.1
Recent data indicate that ClC-5 is an electrogenic Cl/Hþ -
exchanger2,3 rather than a Cl-channel, as thought pre-
viously. Loss-of-function mutations in ClC-5 underlie Dent’s
disease,4 an X-linked renal disorder characterized by low
molecular weight proteinuria, hyperphosphaturia, hypercalci-
uria, and more variable symptoms like kidney stones, rickets,
nephrocalcinosis, and progressive renal failure.5
The mechanisms underlying the pathology of Dent’s
disease were investigated using knockout (KO) mouse
models.6,7 Consistent with the proposed role of ClC-5 in
neutralizing currents of vesicular proton pumps, proximal
tubular endosomes of KO animals acidified more slowly and
to a lesser extent than wild-type (WT) vesicles.8 The
disruption of ClC-5 led to a severe impairment of both
fluid-phase and receptor-mediated endocytosis in the PT.6
A defect in intracellular trafficking is the likely cause of
the observed decreased abundance of megalin,6 an apical
scavenger receptor for a large variety of proteins and other
substances. This decrease in megalin expression further
reduces receptor-mediated endocytosis.
Whereas the loss of low molecular weight proteins per se
has no negative impact on the organism, the loss of hormones
and vitamins that are normally endocytosed in the PT has
important consequences. On the one hand, a significant
urinary loss of a vitamin may result in pathologically low
serum concentrations. On the other hand, the decrease in
proximal tubular endocytosis may raise the concentration of
the hormone or vitamin in the lumen of later nephron
segments. In the presence of apical hormone receptors, this
may cause an abnormally high stimulation of signalling
pathways. Indeed, the analysis of ClC-5 KO mice suggested
that the decreased endocytosis of parathyroid hormone
(PTH) entails an increased stimulation of proximal tubular
apical PTH receptors.6 This, in turn, enhances the endocytosis
and degradation of the Na-phosphate co-transporter NaPi-2a
that mediates the bulk of phosphate reabsorption in the PT.6,9
Hence, the hyperphosphaturia observed in Dent’s disease
may be an indirect consequence of impaired endocytosis.
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Additionally, the increased luminal PTH levels should
stimulate the transcription of 25(OH)-vitamin D3-1a-
hydroxylase (also known as CYP27B1),8 which is mainly
active in the PT. This enzyme converts the vitamin D3
precursor 25(OH)-vitamin D3 into the active compound
1,25(OH)2-vitamin D3. On the other hand, most of the
precursor 25(OH)-vitamin D3 is supplied to this mitochon-
drial enzyme through the apical endocytosis of a 25(OH)-
vitamin D3/binding protein complex.
10 As this process
depends on ClC-5 and megalin, the delivery of the precursor
to the 1a-hydroxylase is severely reduced in the absence of
ClC-5. These alterations (increased amount of the enzyme,
scarcity of the precursor, and loss of active metabolite into
the urine) have opposing effects on 1,25(OH)2-vitamin D3
serum levels. The outcome probably depends on nutritional
and genetic factors. In Dent’s disease patients, serum
1,25(OH)2-vitamin D3 levels were mostly increased,
5,11
whereas in our ClC-5 KO mouse model, serum levels of the
precursor and of the active metabolite were decreased.8
1,25(OH)2-vitamin D3 is a key regulator of calcium
homeostasis. It influences renal Ca2þ excretion, intestinal
Ca2þ absorption as well as bone Ca2þ uptake and release.12
The increased 1,25(OH)2-vitamin D3 levels in Dent’s disease
patients may indirectly cause hypercalciuria and kidney
stones by stimulating intestinal Ca2þ absorption. Our mouse
model displayed decreased 1,25(OH)2-vitamin D3 levels in
the absence of hypercalciuria,6,8 whereas a different ClC-5 KO
mouse had increased 1,25(OH)2-vitamin D3 levels and
hypercalciuria.7,13 These findings reflect the phenotypical
variability found in Dent’s disease.
We now used gene expression profiling to identify other
possible signalling pathways that might be changed in ClC-5
KO kidneys. We identified 1,25(OH)2-vitamin D3-dependent
genes as upregulated in kidney, but not in bone or intestine,
suggesting that a luminal increase in 1,25(OH)2-vitamin D3
concentration selectively activates renal 1,25(OH)2-vitamin
D3 target genes in nephron segments that are distal to the PT.
Renal retinoic acid-dependent genes may be affected by a
similar mechanism.
RESULTS AND DISCUSSION
To further elucidate the pathways leading from the disruption
of ClC-5 to the complex pathology of Dent’s disease, we
performed gene expression profiling of ClC-5 KO kidneys. Of
the B36 000 full-length genes and expressed sequence tag
clusters analyzed on the Affymetrix murine genome array
(U74v2) (http://www.affymetrix.com/products/arrays/speci
fic/mgu74.affx), the transcript levels of 58 genes significantly
differed from WT kidneys (according to the criteria described
in Materials and Methods). The 25 genes that were down-
regulated, and the 33 genes that were upregulated in ClC-5
KO kidneys are given in the Supplementary Tables S2A and
S2B, respectively. A selection of genes that were further
validated by quantitative reverse transcriptase-polymerase
chain reaction (qRT-PCR) and that are discussed in this work
are listed in Table 1. Additional genes that were evaluated by
qRT-PCR are found in the Supplementary Table S1.
Changes in transcript levels of 1,25(OH)2-vitamin
D3-associated genes in ClC-5 KO kidneys
The most striking result of the expression profiling was the
changed transcript levels of genes that are targets of
1,25(OH)2-vitamin D3 or are involved in its metabolism
(Table 1, Figure 1a–c). The largest increase in transcripts
(B350% of WT level) was observed for 25(OH)-vitamin
D3-1a-hydroxylase, which generates the active hormone
1,25(OH)2-vitamin D3 by hydroxylating its inactive precur-
sor.12 This finding confirms previous Northern blot and
RT-PCR data.8 In parallel to the upregulation of the 1a-
hydroxylase, transcripts of vitamin D3 24-hydroxylase (also
known as CYP24A1) were decreased to B10% of WT
levels. This enzyme converts the active hormone 1,25(OH)2-
vitamin D3 and its precursor 25(OH)-vitamin D3 to the
largely inactive metabolites 1,24,25(OH)3-vitamin D3 and
24,25(OH)2-vitamin D3, respectively.
14 The increase of the
activating enzyme and the decrease of the inactivating
enzyme is expected to generate larger amounts of the active
hormone 1,25(OH)2-vitamin D3.
Table 1 | Genes differentially expressed in kidneys of ClC-5
KO micea
Chip (%) RT (%) s.e.m. (%) GeneBank Gene description
Vitamin D/calcium
349 498 187 AB006034 25-Hydroxyvitamin D
1a-hydroxylase
235 212 27 U49430 Ceruloplasmin
152 160 13 AI839138 Thioredoxin-interacting
protein (txnip)
139 142 7 AF028071 Calbindin D-9k
— 146 8 XM_112633 TrpV5 (ECac1)
— 136 31 NM_022413 TrpV6 (ECac2)
— 127 11 D26352 Calbindin D-28k
13 4 5 D89669 Vitamin D 24-hydroxylase
(Cyp24a1)
Renin–angiotensin system
153 135 5 AA690434 Angiotensin I-converting
enzyme II (ACEII)
— 123 27 J00621 Renin
— 116 14 BC054387 Angiotensinogen
Miscellaneous
59 29 44 X66976 Collagen a1
type VIII (Col8A1)
54 64 13 M34094 Midkine (Mdk)
Abbreviations: KO, knockout mice; RT, room temperature; s.e.m., standard error of
the mean; TrpV, transient receptor potential vanilloid.
aThe ratio of transcript levels in the ClC-5 KO is given in % of WT levels. The first
column gives results from the Affymetrix chip analysis, and the second column from
quantitative RT-PCR. The third column gives the s.e.m. for the qRT-PCR data, which
were performed with at least three pairs of WT and ClC-5 KO animals. As several
interesting genes were not represented on the used Affymetrix chips, selected
genes were investigated by qRT-PCR only. The third and fourth columns give the
GeneBank Accession number for the genes, and a description of their gene product,
respectively. Genes are grouped into functional categories. Complete lists of genes
significantly deviating from WT are given in the Supplementary data, and the
complete Affymetrix data set has been submitted to the ArrayExpress database
(www.ebi.ac.uk/arrayexpress) under Accession number E-MEXP-495.
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The changed expression of these vitamin D3-metabolizing
enzymes may be entirely secondary to the primary endo-
cytosis defect in ClC-5 KO PTs (Figure 2a and b). The impaired
endocytosis of PTH should raise the PTH concentration in
the nephron lumen. Increased urinary concentrations of PTH
were indeed found both in ClC-5 KO mice6 and in Dent’s
disease patients.15 The ensuing increased stimulation of
apical proximal tubular PTH receptors6 (Figure 2b) will
enhance the transcription of 25(OH)-vitamin D3-1a-hydro-
xylase16,17 and decrease the stability of vitamin D3 24-
hydroxylase mRNA.18
In addition, the decreased proximal tubular endocytosis
of 1,25(OH)2-vitamin D3, together with its reduced serum
concentration that is a consequence of the impaired
endocytosis, should decrease the concentration of the active
hormone in proximal tubular cells. This is expected to further
contribute to the observed reduction in 24-hydroxylase
transcript levels, as its promoter is activated by 1,25(OH)2-
vitamin D3.
19
The expression of numerous 1,25(OH)2-vitamin D3 target
genes was increased in ClC-5 KO kidney (Table 1). For
instance, mRNA levels of thioredoxin-interacting protein
(txnip) were increased by 52%. Txnip was first identified as a
gene upregulated by 1,25(OH)2-vitamin D3 in HL-60 cells
and was therefore initially called vitamin D3 upregulated
protein 1.20 This ubiquitous protein binds to thioredoxin and
inhibits its ability to reduce sulfhydryl groups.21 Transcripts
of calbindin D-9k, an intracellular Ca2þ buffer important for
Ca2þ reabsorption,22 were increased to 139% of WT levels.
Calbindin D-9k contains a vitamin D3-responsive element
in its promoter.23,24 The induction of calbindins in the
distal nephron is among the most pronounced effects of
1,25(OH)2-vitamin D3.
25
qRT-PCR experiments confirmed these results (Table 1,
Figure 1a–c) and were extended to important 1,25(OH)2-
vitamin D3 target genes that were not represented on
the Affymetrix chips (Table 1, Figure 1a–c). The mRNA
for TrpV5 (also known as ECaC1), an apical Ca2þ -channel
involved in distal Ca2þ reabsorption,26,27 was increased to
146% of WT.
The upregulation of numerous 1,25(OH)2-vitamin D3
target genes in ClC-5 KO kidneys seemed to contradict our
previous finding that serum concentrations of 1,25(OH)2-
vitamin D3 were decreased in the KO.
8 To exclude that
1,25(OH)2- and 25(OH)-vitamin D3 levels differed in the
present mouse generation, new experiments confirmed that
both the active metabolite and its precursor were decreased
in ClC-5 KO sera (Figure 1d and e). Hence, the changes in
PT hydroxylases cannot compensate for the renal loss of
1,25(OH)2- and 25(OH)-vitamin D3. These results suggested
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Figure 1 | Expression of vitamin D3-related genes and 1,25(OH)2- and 25(OH)-vitamin D3 levels. (a) Transcript levels of the activating
enzyme 25(OH)2-vitamin D3 1a-hydroxylase (1a-Hyd) and of the inactivating enzyme 24-hydroxylase (24-Hyd) as determined by qRT-PCR.
Values are depicted in % of WT level, the latter being displayed as a dotted line. (b) Agarose gels showing RT-PCR analysis for these enzymes in
two mouse pairs (top and bottom). The housekeeping gene hypoxanthine-guanine phosphoribosyl-transferase (HPRT) served as control.
(c) Increased renal expression of 1,25(OH)2-vitamin D3 target genes as determined by qRT-PCR (n¼ 6). D-9k and D-28k refers to the respective
calbindins. Genes displayed in dark gray were identified by gene chip analysis and confirmed by qRT-PCR, whereas genes displayed in light
grey were determined only by qRT-PCR as they were not represented on the Affymetrix chips. The dotted line indicates WT level. (d) The serum
concentration of 25(OH)-vitamin D3 is decreased to 20% of WT levels in ClC-5-deficient mice, whereas (e) the active metabolite 1,25(OH)2-
vitamin D3 is decreased to 50% of WT in the KO. (f) The ratio of the active hormone over the precursor shows a B3-fold increase in ClC-5 KO
mice, reflecting the increased renal expression of 1a-hydroxylase and the downregulation of the enzyme 24-Hyd.
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that intrarenal rather than systemic 1,25(OH)2-vitamin D3
stimulates the transcription of renal target genes.
In a complex with their binding protein, 1,25(OH)2-
vitamin D3 and other vitamin D3 metabolites are filtered into
the urine, from which they are normally reabsorbed in
a megalin-dependent manner in the PT10 (Figure 2a). This
efficiently delivers 25(OH)-vitamin D3 to the activating
enzyme 1a-hydroxylase and almost completely recovers
1,25(OH)2- and 25(OH)-vitamin D3 for the organism. The
binding protein, in contrast, is degraded in lysosomes. Upon
the disruption of either ClC-5 or megalin, vitamin D3-
binding protein, 1,25(OH)2-, and 25(OH)-vitamin D3 are
lost into the urine.6,10 Thus, similar to the increased luminal
PTH concentration in ClC-5 KO mice,6 1,25(OH)2-vitamin
D3 should be increased in the tubular fluid of these
mice (Figure 2b and c). Owing to the progressive urinary
concentration, luminal 1,25(OH)2-vitamin D3 concentra-
tions may exceed normal plasma levels in KO mice even
in the presence of reduced serum concentrations. These
considerations predict that an upregulation of 1,25(OH)2-
vitamin D3 target genes occurs only in nephron segments
distal to the PT (Figure 2c). These nephron segments, which
are known to respond to 1,25(OH)2-vitamin D3, are devoid
of the endocytotic receptor megalin. Like in most cells, the
hydrophobic sterol hormone 1,25(OH)2-vitamin D3, after
having dissociated from its binding protein, presumably
diffuses over their plasma membranes as stated by the ‘free
hormone’ hypothesis.28–30 Such an uptake may occur with
comparable efficiency from the tubular fluid or the blood.
In the PT, by contrast, 1,25(OH)2-vitamin D3-stimulated
genes should be downregulated owing to the impaired apical
endocytotic uptake of 1,25(OH)2- and 25(OH)-vitamin D3
(Figure 2a and b), by which these cells normally accumulate
these metabolites.
As predicted from the model (Figure 2), all those
1,25(OH)2-vitamin D3-stimulated genes that were upregu-
lated are expressed in distal nephron segments. The
expression of calbindin-D9k and of TrpV5 is known to begin
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Figure 2 | Model for the impact of impaired proximal tubular endocytosis on vitamin D3 metabolism and signalling. (a) Events in the
early PT: PTH is filtered into the primary urine from which it is normally partially removed by megalin-mediated endocytosis and subsequent
degradation. This pathway depends critically on ClC-5. The uptake of 1,25(OH)2- and 25(OH)-vitamin D3, which are filtered into the urine
together with their binding protein DBP and are endocytosed after binding to megalin, is also impaired. (b) Events in the late PT: The defect in
ClC-5-dependent endocytosis raises the luminal PTH concentration. The ensuing enhanced stimulation of luminal PTH receptors, together with
the strongly decreased apical uptake of 1,25(OH)2-vitamin D3, enhances the transcription of the mitochondrial enzyme 1a-hydroxylase (1a-HYD)
that catalyzes the conversion of the vitamin D3 precursor 25(OH)-vitamin D3 into the active metabolite 1,25(OH)2-vitamin D3, while decreasing
the amount of the catabolizing enzyme 24-hydroxylase. However, the precursor 25(OH)-vitamin D3 reaches the enzyme mainly by megalin-
dependent apical endocytosis, which is severely impaired. Furthermore, both the precursor and the active hormone are lost into the urine.
Hence, there is a delicate balance between the changed transcription of enzymes that co-operates to increase active vitamin D3, and the loss of
the precursor and active form into the urine. Depending on the outcome (increased or decreased concentration of active vitamin D3 in serum),
this leads to different clinical phenotypes. (c) Events in the distal tubule: 1,25(OH)2-vitamin D3 enters distal tubular cells by diffusion over the
membrane and binds to the vitamin D3 receptor which activates the transcription of 1,25(OH)2-vitamin D3 dependent genes after
heterodimerization with the RXR. As the concentration of 1,25(OH)2-vitamin D3 is increased in the lumen of ClC-5 KO kidneys, renal
1,25(OH)2-vitamin D3 target genes are selectively affected. D-9k: Calbindin D-9k.
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in the distal convoluted tubule.31 The renal localization of
txnip has not yet been described. In situ hybridization
revealed a predominant medullar in addition to a weaker
cortical expression (Figure 3). This is consistent with its
upregulation occurring in the distal nephron. By contrast, the
1,25(OH)2-vitamin D3-inducible 24-hydroxylase is very
predominantly expressed in PTs (Supplementary Figure S1).
Accordingly, its mRNA levels were drastically decreased in
whole kidneys (Figure 1a and b). qRT-PCR on microdis-
sected PTs confirmed this downregulation and revealed an
upregulation in the distal convoluted tubule (Supplementary
Figure S1), just as predicted by the model.
Expression of 1,25(OH)2-vitamin D3-regulated genes is
unchanged in the intestine and bone
In line with the hypothesis that a local accumulation of
1,25(OH)2-vitamin D3 in the nephron lumen accounts for
the renal upregulation of 1,25(OH)2-vitamin D3 target genes,
expression profiling of bone and intestine, the two other
main 1,25(OH)2-vitamin D3 target organs, failed to reveal
any upregulation of 1,25(OH)2-vitamin D3-stimulated genes
(Supplementary Tables S3 and S4). For instance, neither
osteocalcin nor osteopontin, which both contain vitamin D3-
responsive promoter elements,32 showed detectable changes
in transcript levels. Hence, the upregulation of 1,25(OH)2-
vitamin D3-dependent genes is indeed kidney-specific. In
view of the decreased serum levels of 1,25(OH)2-vitamin D3,
it seems rather surprising that these genes were not down-
regulated. However, this agrees with their unchanged
transcript levels in 1a-hydroxylase KO mice that also display
decreased 1,25(OH)2-vitamin D3 serum levels.
33
Comparison to megalin KO mice
Megalin is a multi-ligand scavenger receptor involved in
proximal tubular endocytosis of a large number of filtered
proteins. Whereas 25(OH)2- and 1,25(OH)2-vitamin D3
endocytosis is severely reduced in the absence of ClC-5, it
is nearly totally abolished in megalin KO mice. The ensuing
severe 1,25(OH)2-vitamin D3 deficiency leads to bone defects
in megalin KO mice.10
As the loss of ClC-5 or megalin affects receptor-mediated
endocytosis to different degrees, it is interesting to compare
our results to the expression profiling of megalin KO mice.
Table 2 lists transcripts that were found to be changed in
kidneys of megalin KO mice,34 and compares their expression
levels with those in ClC-5 KO kidneys. Similar to ClC-5 KO
mice, the expression of 25(OH)-vitamin D3-1a-hydroxylase
was increased in the megalin KO up to 400% and the
24-hydroxylase was decreased to 8–30%.34 Of the 11 additional
genes reported to be differentially regulated in the megalin
KO,34 only three were significantly changed in ClC-5 KO
kidneys (Table 2). A very strong increase in expression (to
B300%) was observed for 24p3, the mouse gene encoding
lipocalin 2, a secreted carrier of hydrophobic ligands and
iron that might play a role in renal iron transport.35 Its
transcription can be induced by retinoic acid, among other
Table 2 | Comparison of differentially expressed genes
between ClC-5 KO and megalin KO micea
Megalin KO
ClC-5 KO
GeneBank Gene description
Chip (%)
RT
(%)
s.e.m.
(%)
400 (RT) 498 187 AB006034 25-Hydroxyvitamin D
1a-hydroxylase
190–920 (3/4) 338 103 X81627 Lipocalin-encoding
gene 24p3
170–330 (3/4) 212 27 U49430 Ceruloplasmin
190–300 (3/4) 145 36 X70296 Serine protease inhibitor 4
250–910 (4/4) 138 26 X52046 Collagen type III aI (COL3A1)
290–430 (3/4) 137 15 V00835 Metallothionein I
120–230 (3/4) 126 14 X54149 MyD118
240–990 (4/4) 124 10 X62600 CCAAT/enhancer-binding
protein b (C/EBP b)
2.4–8.3 (4/4) 122 17 AA109196 Megalin
170–210 (3/4) 111 5 X62940 TGFb-stimulated clone 22
43.5–83 (3/4) 100 10 U61085 Thiazide-sensitive NaCl
cotransporter
7.9–27 (4/4) 4 5 D89669 Vitamin D 24-hydroxylase
(Cyp24a1)
160–330 (3/4) 87 8 M62766 HMG CoA reductase
41.7–71 (3/4) 93 5 AA002852 Non-POU domain-
containing protein
Abbreviations: KO, knockout mice; RT, room temperature; s.e.m., standard error of
the mean.
aThe table lists genes that were published34 as being differentially regulated in
megalin KO mice kidneys. As in Table 1, GeneBank Accession numbers and a
description of the gene product are given in columns 4 and 5, respectively. Column
1 states the changes in transcript levels in the megalin KO (in % of WT) observed in
three (3/4) or four out of four (4/4) individual gene chip experiments.34 Except for
the 1a-hydroxylase, the data for the megalin KO were obtained by Affymetrix chip
analysis. Column 2 indicates our qRT-PCR results (in % of WT) for these transcripts in
ClC-5 KO mice. The third column gives the standard error of the mean (s.e.m.) for the
qRT-PCR data, which were performed with at least three different pairs of WT and
ClC-5 KO animals.
G G
a
c
b
d
Figure 3 | Localization of txnip mRNA within the kidney. (a) In situ
hybridization of txnip transcripts revealed predominant expression in
kidney medulla with a scarce, scattered expression in the cortex.
(c) and (d) give a original magnification  10 of medulla and cortex,
respectively. (b) The control hybridization with an unspecific probe,
which yielded only weak background staining. The bar corresponds
to 1.5 mm in (a) and (b) and to 100 mm in (c) and (d). Glomeruli are
marked by a G in (c). Bar¼ (a, b) 1.5 mm, (c, d) 100 mm.
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mechanisms.36 As retinol-binding protein and its ligands are
endocytosed in a megalin-dependent manner in the PT37 and
are hence lost into the urine of both megalin and ClC-56 KO
animals, one may speculate that the induction of 24p3 might
be owing to an intraluminal accumulation of retinol-binding
protein and its ligands. On the other hand, the growth factor
midkine, which can also be induced by retinoic acid,38,39 was
rather decreased in ClC-5 KO kidneys (Table 1). This fits well
with the expression of these genes along the nephron:
midkine is highly expressed in PTs,40 whereas 24p3 is
expressed in distal tubule segments.41 Together with our
finding that the serum concentration of retinol did not differ
between WT and KO (Supplementary Figure S2), this
suggests a mechanism like the one proposed for
1,25(OH)2-vitamin D3. Owing to the defective proximal
tubular endocytosis of retinol-binding protein and its bound
retinol metabolites, retinoic acid target genes are down-
regulated in the PT, but are upregulated in the distal tubule as
a consequence of the luminal accumulation of retinol-
binding protein complexes.
The two other genes that are differentially regulated in
both megalin and ClC-5 KO mice encode proteins that are
also involved in metal binding. One of them, ceruloplasmin,
which was upregulated toB210%, functions as a ferroxidase
and binds about 95% of the copper found in plasma.42 The
other protein, metallothionein (MT) (B140%), is a metal-
scavenging protein that transports cadmium (Cd2þ ) in the
serum. MT-Cd2þ complexes are endocytosed in a megalin-
dependent manner in the PT,43 and MT expression is
upregulated by Cd2þ ,44 possibly suggesting that reduced
Cd2þ endocytosis in the PT induces MT in later segments.
Furthermore, administration of 1,25(OH)2-vitamin D3 to
mice increased their renal MT mRNA levels,45 suggesting that
the observed upregulation of MT might depend on the
1,25(OH)2-vitamin D3 pathway discussed above. The same
holds true for ceruloplasmin, which was increased fivefold
after 1,25(OH)2-vitamin D3 administration.
46
Beside these concordant changes in gene expression in
megalin- and ClC-5 KO mice, several genes were differentially
expressed in only one of these mouse models. This is not
unexpected, because megalin-dependent endocytosis is only
partially abolished in ClC-5 KO mice, and because the
disruption of ClC-5 also affects other endocytotic processes
like fluid-phase endocytosis and the endocytotic retrieval of
certain plasma membrane proteins.6 Whereas ClC-5 KO mice
did not show detectable structural abnormalities of the PT,47
pronounced morphological changes in apical endocytotic
compartments were observed in megalin KO mice.48 These
changes indirectly affect other endocytotic processes like the
retrieval of NaPi-2a.49 Unlike ClC-5 KO mice, megalin KO
mice have severe extrarenal pathological changes.50
The remaining genes that were changed in ClC-5 KO
kidneys can be sorted into three main groups: enzymes,
transporters, and signalling proteins (Supplementary
Table S1). There is currently no good explanation for their
differential expression.
Comparison to other ClC-5 KO mice and functional
consequences
A second, independent ClC-5 KO mouse model has been
published by Guggino et al.7 It also displays a drastic
reduction of proximal tubular endocytosis. Although the
gene disruption strategy and the genetic background do not
offer obvious reasons for phenotypical differences, their mice
display hypercalciuria, unlike our KO mice. Because in their
mice serum levels of 1,25(OH)2-vitamin D3 were moderately
elevated,13 whereas they were reduced in our line (8 and
Figure 1d and e), their hypercalciuria might be explained
by increased intestinal Ca2þ reabsorption as discussed for
Dent’s disease.51 The renal upregulation of the calbindins
and TrpV5 in our KO line should increase renal Ca2þ
reabsorption, which is consistent with the lack of hyper-
calciuria in our mouse strain.
Whereas bone turnover markers were reported to be
elevated in the ClC-5 mouse model of Guggino and
co-workers,13 our microarray analysis of bone mRNA did
not reveal changed expression of genes involved in bone
metabolism. Hence, the bone phenotype described by Silva
et al.13 is unlikely to represent a tissue-intrinsic effect of the
ClC-5 disruption, but might rather be owing to secondary
effects of hypercalciuria and hormonal changes. It would be
interesting to compare our results with an expression analysis
of the other ClC-5 KO mouse,7 which, however, is not yet
available.
In the present microarray analysis, angiotensin I-convert-
ing enzyme II expression showed a 35% increase. Angiotensin
I-converting enzyme II is an important part of the
renin–angiotensin system. In addition to its well-known role
in blood pressure regulation, this system is implicated in the
progression of renal damage.52 In bicinchoninic acid-over-
loaded rats, a model for proteinuria, angiotensin-converting
enzyme mRNA was increased by 110%.53 Hence, the increase
in its homolog angiotensin I-converting enzyme II in ClC-5
KO mice might be secondary to their proteinuria. Whereas
renin and angiotensinogen transcript levels were changed in
the rat proteinuria model,53 it was unaltered in ClC-5 KO
kidneys. Renin transcription may be inhibited by 1,25(OH)2-
vitamin D3.
54 However, the granular cells that synthesize
renin will rather experience the blood concentration of
1,25(OH)2-vitamin D3 as they are separated from the tubular
lumen by macula densa cells.
Our microarray analysis did not detect differences in genes
implicated in degenerative or fibrotic changes, alterations
that can be found in Dent’s disease. The collagen-encoding
gene COL8A1, which was upregulated after vascular injury55
was even downregulated to 59%. However, we cannot exclude
that expression changes indicative of inflammation and
fibrosis occur in animals that are older than the 8-week-old
mice we have analyzed.
In summary, our data suggest that the luminal accumula-
tion of vitamins and hormones that results from decreased
proximal tubular endocytosis has important physiological
consequences. In our mouse model for Dent’s disease, this
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cascade of events does not only include the previously
described effects of PTH but also 1,25(OH)2-vitamin D3 and
its target genes and may even extend to genes activated by
retinoic acid. Such effects may also be seen with other forms
of Fanconi syndrome.
MATERIALS AND METHODS
Preparation of biotin-labelled cRNA from WT and ClC-5 KO
organs for microarray analysis
Three 8-week-old C57Bl/6J WT and ClC-5 KO littermates were used
per organ. Total RNA was prepared from the kidney, intestine, and
bone using TRIZOL (Invitrogen, Carlsbad, CA, USA) and purified
with RNeasy columns (Qiagen, Hilden, Germany). cDNA synthesis
used the SuperScriptTM Double-Stranded cDNA Synthesis Kit
(Invitrogen). Biotin-labelled cRNA was produced with the BioArray
HighYield RNA Transcript Labelling Kit (Enzo, New York, NY, USA)
and was purified with RNeasy Mini columns (Qiagen).
Hybridization and scanning of microarrays
Purified cRNA (15 mg) were fragmented at 941C for 30 min in buffer
containing 40 mM Tris-acetate, pH 8.1, 100 mM KOAc, and 30 mM
MgOAc. The labelled cRNA was hybridized to Affymetrix Murine
Genome Array U74Av2 (for kidney) or MOE 430 A/B (for bone
and intestine) according to the Affymetrix manual. The quality of
the RNA was analyzed by hybridization of Affymetrix Test 3 chips.
Washed and stained microarrays were analyzed with a GeneArray
scanner (Agilent, Palo Alto, CA, USA).
Evaluation of microarrays
The following programs were used: Affymetrix Microarray Suite
Version 5.0, Affymetrix MicroDB Version 3.0, and Affymetrix Data
Mining Tool Version 3.0. We used the statistical analysis of the Data
Mining Tool program and the pairwise comparison of all KO RNAs
vs all WT RNAs of the Microarray Suite program. Genes found to be
differentially expressed in at least 55% of the pairwise comparisons,
as well as significantly changed in the statistical analysis judged by
the Mann–Whitney test, were further investigated and are included
in the Supplementary data.
Validation of differentially expressed genes by qRT-PCR
Total RNA was prepared from kidney, intestine, and bone of 8-week-
old ClC-5 KO and WT littermates using TRIZOL (Invitrogen) and
digested with RNAse-free DNase (Ambion, Austin, TX, USA) before
purification with RNeasy columns (Qiagen). cDNA synthesis used
SuperScriptTM II reverse transcriptase, oligo(dT)15 primer, first-
strand reaction buffer, 0.1 M dithiothreitol, 10 mM deoxynucleoside
triphosphate mix, and RNaseOUT (Invitrogen). The qRT-PCR was
run in an ABI PRISM 7700 Sequence detection System (SDS 2.1
software) using the SYBR green PCR master mix (Applied
Biosystems, Foster City, CA, USA). Primers were designed with
the Primer Express Software (Applied Biosystems). For sequences,
see Table S5 of Supplementary data. Reactions were performed in
triplicate with cDNAs from at least three different animal pairs. Fold
changes were calculated and geometrically averaged.
Dissection and qRT-PCR analysis of nephron segments
Nephron segments (PT, distal convoluted tubule) were obtained by
microdissection of collagenase (C-6885; Sigma, St Louis, MO, USA)
perfused kidneys as described.56 cDNA was prepared as described
by Elalouf et al.57 and used for qRT-PCR (see above).
Analysis of differentially expressed genes by RT-PCR
Non-qRT-PCR was performed in 50 ml (5 ml 10PCR reaction
buffer (Invitrogen), 2 ml 50 mM MgCl2, 0.5 ml. Taq DNA polymerase
(Invitrogen), 1ml diluted cDNA, and 10 pmol of each primer) with
5 min at 941C; three cycles of 20 s 941C, 20 s 601C, 20 s 721C; 37
cycles of 20 s 941C, 20 s 581C, 20 s 721C, and a final step of 5 min
721C.
Analysis of 25(OH)-vitamin D3, 1,25(OH)2-vitamin D3, and
retinal
To measure serum hormones, serum from ClC-5 KO and WT blood
was obtained by centrifugation. 25(OH)-vitamin D3 was determined
with the OCTEIA assay (IDS, Frankfurt, Germany) and 1,25(OH)2-
vitamin D3 by radioimmunoassay (Nichols Institute Diagnostics,
Bad Vilbel, Germany). Retinol was analyzed in the laboratory of Dr
Rainer Ru¨ter (Hamburg, Germany).
In situ hybridization on kidney sections
A 321 bp mouse txnip fragment covering 32–453 bp of the mouse
gene was subcloned into pBluescript. A 353 bp mouse 24-
hydroxylase fragment covering 957–1310 bp was subcloned likewise.
Antisense and sense (control) radioactive probes were transcribed
from the linearized vector using 35S-UTP and either T3 or T7 RNA
polymerase (Maxiscript; Ambion). Kidney sections were hybridized
as described.58 They were exposed to Kodak Biomax X-ray film,
followed by dipping into a photoemulsion.
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